Extensions

To provide accurate and up-to-date information on patent term adjustments (PTA), patent term extensions (PTE), continuation applications, divisional applications, related family members, and the projected expiration date for US patent 10083154, direct access to the USPTO's Patent Center or Patent Public Search is required. The USPTO does not calculate expiration dates for patents itself but provides tools and guidance for estimating them.

Based on the information available in the patent document and general patent law:

Patent Term Adjustments (PTA)
PTA is granted to compensate for certain delays caused by the USPTO during the prosecution of a patent application. The America Invents Act of 1999 established PTA, which adds days to the 20-year lifespan of a utility or plant patent. PTA can be accrued for various reasons, including the USPTO failing to issue an office action within 14 months of filing, failing to respond to an applicant's reply within four months, or if the patent does not issue within 36 months of its filing date. Applicant delays can reduce the period of adjustment. The USPTO automatically determines the PTA and provides notice no later than the patent's issuance date.

To determine the specific PTA for US patent 10083154, one would typically consult the Issue Notification Letter or the patent's file history in Patent Center. Without direct access to these USPTO systems for this specific patent, the exact PTA amount cannot be determined from the provided text.

Patent Term Extensions (PTE)
PTEs are available for patents covering certain human drugs, food or color additives, medical devices, animal drugs, and veterinary biological products to restore a portion of the patent term lost during regulatory review by agencies like the FDA. This is governed by the Hatch-Waxman Act. A PTE cannot exceed five years, and the total patent term, including the extension, cannot exceed 14 years from the date of marketing approval. "Pediatric exclusivity" can provide an additional six-month extension for innovator pharmaceutical companies conducting research for pediatric patients.

Given that US patent 10083154 relates to "Scalable display of internet content on mobile devices," it does not fall within the categories of products eligible for PTE under the Hatch-Waxman Act. Therefore, it is highly unlikely to have any PTE.

Continuation Applications, Divisional Applications, and Related Family Members
US patent 10083154 is explicitly identified as a "Continuation" of several earlier applications. These form part of its patent family and share common subject matter.

The patent text "CROSS-REFERENCE TO RELATED APPLICATION" section details its lineage:

• Continuation of: U.S. Non-provisional application Ser. No. 12/941,106, filed Nov. 8, 2010 (issued as U.S. Pat. No. 9,519,729).
• Which is a Continuation of: U.S. Non-provisional application Ser. No. 11/738,486, filed Apr. 21, 2007 (to be issued as U.S. Pat. No. 7,831,926).
• Which is a Continuation of: U.S. Non-provisional application Ser. No. 09/878,097, filed Jun. 8, 2001 (issued as U.S. Pat. No. 7,210,099).
• Which is a Continuation-in-Part of: U.S. Non-provisional application Ser. No. 09/828,511, filed Apr. 7, 2001 (Abandoned).

Additionally, U.S. Non-provisional application Ser. No. 09/878,097 further claims the benefit of:

• U.S. Provisional Application No. 60/211,019, filed Jun. 12, 2000.
• U.S. Provisional Application No. 60/217,345, filed Jul. 11, 2000.

The application also contains subject matter related to Divisionals (of U.S. Non-provisional application Ser. No. 09/878,097):

• U.S. Non-provisional application Ser. No. 11/045,649 (issued as U.S. Pat. No. 7,584,423), filed Jan. 28, 2005.
• U.S. Non-provisional application Ser. No. 11/045,757 (issued as U.S. Pat. No. 7,461,353), filed Jan. 28, 2005.

Further related applications include:

• U.S. Non-provisional application Ser. Nos. 11/735,477 and 11/735,482, both filed on Apr. 15, 2007.
• U.S. Non-provisional application Ser. No. 11/738,932 filed on Apr. 23, 2007.
• U.S. Non-provisional application Ser. No. 11/868,124 filed on Oct. 5, 2007.
• U.S. Non-provisional application Ser. No. 12/326,092 filed on Dec. 1, 2008.

These applications constitute the patent family for US patent 10083154, demonstrating a continuous chain of applications claiming priority back to the earliest provisional filing dates. A continuation application is a second application for the same invention claimed in a prior non-provisional application and is filed while the original application is still pending. A divisional application is filed to pursue inventions that were restricted out of a parent application. Both continuation and divisional applications generally retain the filing date of the parent application.

Projected Expiration Date
For applications filed on or after June 8, 1995, the patent term is generally 20 years from the date of the earliest related application for which a benefit is claimed. This 20-year term can be adjusted by PTA.

The earliest priority date for US patent 10083154, as stated in its "CROSS-REFERENCE TO RELATED APPLICATION" section, is June 12, 2000, from U.S. Provisional Application No. 60/211,019. However, "A U.S. provisional application or a foreign application isn't included in that chain" when counting the 20 years from the earliest application in the chain, for applications filed after June 8, 1995. Instead, the 20-year term is counted from the earliest non-provisional application.

The earliest non-provisional application in the chain is U.S. Non-provisional application Ser. No. 09/878,097, filed on June 8, 2001. Therefore, the nominal expiration date would be June 8, 2021 (20 years from June 8, 2001).

However, the patent states its anticipated expiration as 2021-04-07 and also lists its legal status as "Expired - Fee Related". This earlier expiration date of April 7, 2021, suggests that the earliest effective filing date might be April 7, 2001, corresponding to U.S. Non-provisional application Ser. No. 09/828,511 (Abandoned), or there could be a terminal disclaimer that affects the patent term. Terminal disclaimers prevent double patenting and can cause a patent to expire with an earlier patent. Without specific information on terminal disclaimers for US10083154, it is difficult to definitively confirm the exact reason for the April 7, 2021, expiration date.

Since the patent is listed as "Expired - Fee Related" and an anticipated expiration date of April 7, 2021, is provided, the patent has already expired. This means that any PTA that may have been granted would have extended its term beyond the nominal 20 years from its earliest non-provisional filing date (June 8, 2001, which would have meant a nominal expiry of June 8, 2021), but it ultimately expired due to fee-related issues by April 7, 2021.